fashion -WSS

fashion

author：leisure time 2025-10-01 12:34:38 - browse：83792

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans.

The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel starting Tuesday to discuss how to best evaluate safety and effectiveness, as well as the ethical quandaries in running clinical trials. The second day will be closed to the public to shield trade secrets.

Several research teams are racing to build artificial placentas that replicate the uterine environment and give the very prematurely born a better shot at survival. A team at the Children’s Hospital of Philadelphia, led by Alan Flake, is the closest to human trials — their device is a bag filled with sterile fluid, which contains the fetus and is connected to tubes providing oxygen and nutrition.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： FDA scientists endorse Pfizer/BioNTech Covid

focus

WSS

US jobless claims fall again as labor market continues to flash strength

CDC recommends RSV monoclonal antibody for infants

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Dementia risk linked to living in disadvantaged areas: Study

Extensive review finds private equity owners jack up cost of care

Hormonal contraceptives don’t actually treat endometriosis

hotspot

fashion

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

Late stage cancers on the rise after pandemic delayed screenings

State Dept. review finds Biden bears some blame for Afghanistan failures

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Hepatitis C has a cure — but many Americans still lack access to it

Dementia risk linked to living in disadvantaged areas: Study

Jerome Adams on the need for new antivirals for Covid

How a Boston hospital is priming medical residents to use GPT

Drug repurposing or repositioning? The language matters

It costs an awful lot of money to give away a kidney

hotspot

Medicare slashes safety net hospital payments by nearly $1 billion

Dementia risk linked to living in disadvantaged areas: Study

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Sanders wants to replace patents with prizes for drug inventions

FDA scientists endorse Pfizer/BioNTech Covid

Hormonal contraceptives don’t actually treat endometriosis

focus

focus

leisure time

hotspot